<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1965234</identifier>
<setSpec>0370-4106</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Erazo, R</dc:author>
<dc:description xml:lang="en">Myasthenia gravis is the most frequent abnormality of the neuromuscular junction in adults and children. In its milder forms satisfactory management may be obtained with oral neostigmine, but in more severely affected patients steroid therapy and thymus resection may be necessary. Congenital myasthenic syndrome is rather infrequent but timely recognition an identification are very important because treatment and prognosis vary widely in its different forms. Hypermagnesemia, botulism, organophosphate insecticides, are also highlighted among toxic and metabolic causes of neuromuscular junction abnormality.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1990 Sep-Oct </dc:date>
<dc:title xml:lang="es">Miastenia gravis y síndromes miasténicos en el niño.</dc:title>
<dc:title xml:lang="en">[Myasthenia gravis and myasthenic syndromes in children].</dc:title>
<dc:publisher>Revista chilena de pediatria</dc:publisher>
</metadata>
</record>
</pubmed-document>
